Anthony Durkacz’s principal business is director and Executive Vice President at First Republic Capital Corporation (“FRCC”), an exempt market dealer actively engaged in financing and acquiring and investing in arm’s length enterprises, all of which are considered active business for FRCC by both the Canada Revenue Agency and the securities regulators in Canada. Mr. Durkacz and FRCC regularly engage M&A mandates, and also both take an active role in acquiring businesses and technologies to incubate them to prepare for public exits. Mr. Durkacz is also the owner and President of Fortius Research & Trading Corp., which provides financial and investor relations consulting services to micro and small cap companies in various sectors and develops investment strategies for high net worth individuals. He also served as COO and CFO of MKU Canada Inc. engaging in mergers and acquisitions globally, and from 2002 to 2006 he served as the CFO of Astris Energi Inc., a dually listed public company in the USA and Canada which was acquired by an international conglomerate. He began his career at TD Securities on the capital markets trading floor. Mr. Durkacz holds an Honours Bachelor of Business Administration from Brock University with a major in Accounting and Finance. Mr. Durkacz has a track record of acquiring and divesting interests in arm’s-length enterprises in a manner that can be characterized as conducting an active business, including investments in the cannabis section, such as overseeing the initial investments in FV Pharma Inc. (a cannabis grower), High Tide Inc. (a cannabis retailer), Huge Shops Inc. (a cannabis retailer) and IM Cannabis Corp. (an Israeli cannabis grower and distributor). Mr. Durkacz is the chief executive officer, director and chairman of the Board of Directors of the Issuer, and 25% of his time will be devoted to the Issuer.
Mr. Japgal is a founder, director, CFO of Albert Labs International Corp, a CSE listed laboratory based, clinical research and drug development enterprise, focused on improving patient access to psychedelic assisted therapies through accelerated regulatory approval pathways. Past experience includes being the CEO and Director of Grand Peak Capital Corp., an investment issuer listed on the TSX-V and investing in a portfolio of Resource and Technology Companies. Mr. Jagpal has over 20 years of experience in public company management in the medical cannabis, agriculture, biotech, nutraceuticals, real estate development and business software systems industries. Previously, Mr. Jagpal was Director and CEO of Grand Peak Capital Corp., a publicly listed investment issuer on the TSX-V. Mr. Jagpal has his Honours Bachelor in Economics from Simon Fraser University. Mr. Jagpal is the chief financial officer and a director of the Issuer, and approximately 10% of his time will be devoted to the Issuer.
Michael Galloro is an accomplished executive with over 27 years of experience. Michael is the president of ALOE Finance, a transaction services boutique firm, focusing on the small and mid-cap space, and working closely with emerging private and publicly listed companies operating globally, assisting and overseeing their mergers and acquisitions, financings, corporate structuring and go public transactions, both in the Canadian and the US securities markets. In his role as president, Michael closely oversees the operations of ALOE Finance. Michael is also currently the CEO of AF2 Capital Corp, a capital pool company on the TSX Venture Exchange. Michael earned his Chartered Professional Accountant, Chartered Accountant (CPA, CA) designation while working in the financial institutions practice for KPMG LLP and has his Honours Bachelor of Accounting (BAcc) Degree from Brock University. Mr. Galloro has a track record of acquiring and divesting interests in arm’s-length enterprises in a manner that can be characterized as conducting an active business, including investments in the cannabis section, such as overseeing the initial investments in Liberty Health Sciences Inc. (a US chain of medical cannabis dispensaries) and Simply Better Brands Corp. (a CBD brand in the United States). Mr. Galloro is a director of the Issuer, and 10% of his time will be devoted to the Issuer.
Richard Buzbuzian is a capital markets executive with over 20 years of investment experience in Canada and Europe. Currently, Mr. Buzbuzian operates Buzbuzian Capital Corporation, a family office with an investment portfolio of public and pre-IPO companies in the technology sector as well as a variety of special situations. Additionally, Mr. Buzbuzian currently serves on several boards of public, private and nonprofit organizations. Most recently, Mr. Buzbuzian was a cofounder, a major shareholder, and the President of Drone Delivery Canada (FLT: TSXV) and currenty the President and Director of Nugen Medical Devices (NGMD:TSXV). Mr. Buzbuzian holds a degree from the University of Toronto.
Stock Trend Capital is a publicly traded investment issuer that capitalizes on emerging trends. Our mission is to provide exceptional returns by identifying and investing in high-growth opportunities.
